Myriad Genetics, Inc. announced a collaboration with Flatiron Health. This collaboration allows physicians to order Myriad's MyRisk Hereditary Cancer Test and view the results of the test directly in Flatiron's cloud-based Electronic Medical Record (EMR) platform, OncoEMR. The integration allows 4,200 providers at over 800 community-based cancer care locations across the U.S. in Flatiron's network to conveniently order, receive, and review MyRisk testing results directly through their daily OncoEMR system. By creating a streamlined, end-to-end workflow for germline testing in OncoEMR, clinicians have access to the results they need at point-of-care, facilitating personalized treatment decisions for patients while reducing administrative burdens and improving turnaround times for results.

The integration is available now to all OncoEMR users.